Adicet Bio Stock (NASDAQ: ACET) stock price, news, charts, stock research, profile.
Open | $2.140 |
Close | $2.100 |
Volume / Avg. | 1.130M / 1.434M |
Day Range | 2.070 - 2.250 |
52 Wk Range | 1.100 - 7.500 |
Market Cap | $167.594M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 43 |
Short Interest | 10.84% |
Days to Cover | 7.64 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Adicet Bio (NASDAQ: ACET) through any online brokerage.
Other companies in Adicet Bio’s space includes: Zura Bio (NASDAQ:ZURA), Syros Pharmaceuticals (NASDAQ:SYRS), Outlook Therapeutics (NASDAQ:OTLK), Galectin Therapeutics (NASDAQ:GALT) and bluebird bio (NASDAQ:BLUE).
The latest price target for Adicet Bio (NASDAQ: ACET) was reported by Wedbush on Tuesday, April 23, 2024. The analyst firm set a price target for 5.00 expecting ACET to rise to within 12 months (a possible 145.10% upside). 18 analyst firms have reported ratings in the last year.
The stock price for Adicet Bio (NASDAQ: ACET) is $2.04 last updated April 23, 2024 at 5:45 PM EDT.
A quarterly cash dividend of $0.07 per share of Class A Common Stock. The quarterly cash dividend was payable on October 9, 2018 to stockholders of record on September 21, 2018.
Adicet Bio’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Adicet Bio.
Adicet Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.